Video: How Superbugs Get Started.

A World Health Organization (WHO) report released April 2014 stated, "this serious threat is no longer a prediction for the future, it is happening right now...
coronavirus, biotech stock review

VIDEO: Dyadic (DYAI) CEO Explains What his Industry is Doing to Defeat Coronavirus (FoxNews).

Jan. 27, 2020 - 5:24 - Dyadic International CEO Mark Emalfarb discusses what’s being done to stop the spread of coronavirus and to...
Dyadic

Could Dyadic (DYAI) $5.75 Provide a Solution to Help Mass Produce Vaccines to Battle...

Dyadic (DYAI) has developed a biomanufacturing technology platform, nicknamed C1 which helps to speed the development, lower the manufacturing cost and potentially improve the...

CoronaVirus Watch List Stocks in the News (Bloomberg, Benzinga).

INITIAL WATCHLIST: CoronaVirus Watch List | Superbug Stock Review Aethlon Medical, Inc. (NASDAQ: AEMD) $2.40   Alpha Pro Tech, Ltd. (NYSE: APT) $6.00AstraZeneca plc (NYSE: AZN) $49BioCryst Pharmaceuticals, Inc.'s (NASDAQ: BCRX) $2.80  Cerus Corporation (NASDAQ: CERS)...
Citius Pharmaceutical, CTXR, Biotech Stock Review

New Report: Citius Pharma (CTXR) Now Our #1 Ranked Idea for 2020.

Citius Pharmaceuticals (CTXR) is hands down one of the most exciting long-term opportunities we have come across since we first launched the Biotech Stock...

Candida Auris: Hospitals mobilize to fight the deadly infection (Video). More Videos Below.

https://youtu.be/hnqFdKSG6-A Auris all over the room, even on the ceiling?. https://youtu.be/ypyNoM5z40s Are hospitals keeping real-time infection status a secret? https://www.youtube.com/watch?v=IOX3JdLvm1Y ARTICLES: A Mysterious Infection, Spanning the Globe in a Climate...
Dyadic, Biotech Stock Review

Dyadic (DYAI) Highlights.

"In just over a year and a half we have entered into over 15 proof of concept collaborations for both human and animal health...

Adding Citius (CTXR) $0.55 to Watch List.

Best Presentation at Dawson James Conference. We attended the Dawson James Conference on October 29th, which had over 20 medtech and biotech companies. The two...
Dyadic, Biotech Stock Review

Dyadic (DYAI) $7.00 Called a ‘Gamechanger’ – Gets $14 Price Target.

Highly Respected Wall Street Analyst Jason Kolbert Issues $14.00 Price Target On Dyadic. Analyst Take: "Potential to be Revolutionary. Dyadic’s C1 shows potential in...
Dyadic

Investor Presentation Slides From Dyadic (DYA) $6.40.

Really, How Do We Do It? Live Short Term Chart INVESTOR PRESENTATION LONGER TERM CHART Client, see published reports for disclosure and disclaimer details.

Latest article

Cardiol Therapeutics (CRDL) May 2025 Presentation.

Click here to open. RELATED: Cardiol’s (CRDL) Game-Changing Solution for Heart Inflammation? | David Elsley CEO – Video Interview

Nice Bounce on Alkaline Water (WTER) up 81%.

Well now that ain't bad, up 81%! Our outlook on The Alkaline Water Company, our "comeback of the decade" story, is "let's see what...

Zomedica Corp (ZOMDF) $0.05

Company Overview Background Zomedica Corp., incorporated in 2013 under the Business Corporations Act (Alberta), is headquartered in Ann Arbor, Michigan. Initially listed on the TSX Venture...